European Society of Cardiology (ESC) Congress 2023

Amsterdam, The Netherlands 25 August 2023 - 28 August 2023

Semaglutide scores again, this time for HFpEF in obese

03 Oct 2023 by

Once weekly injection of semaglutide causes weight loss in obese patients with heart failure with preserved ejection fraction (HFpEF), with positive shifts in symptoms and improvements in physical limitations in the STEP-HFpEF trial presented at ESC 2023.

Semaglutide scores again, this time for HFpEF in obese

03 Oct 2023

OCT- vs angiography-guided PCI for bifurcation lesions: Which is better?

22 Sep 2023 by

In percutaneous coronary intervention (PCI) for complex bifurcation lesions, optical coherence tomography (OCT) guidance outdid the angiography-guided approach, findings from the OCTOBER* trial have shown.

OCT- vs angiography-guided PCI for bifurcation lesions: Which is better?

22 Sep 2023

Acoramidis may be new player in ATTR-CM

21 Sep 2023 by

Acoramidis has emerged as an important player in the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), demonstrating encouraging results in the phase III ATTRibute-CM trial.

Acoramidis may be new player in ATTR-CM

21 Sep 2023

Extended anticoagulation benefits cancer patients with distal DVT

20 Sep 2023 by

In cancer patients with isolated distal deep vein thrombosis (IDDVT), a 12-month anticoagulation regimen with the oral factor Xa inhibitor edoxaban fared better than a 3-month regimen, findings from the ONCO DVT study have shown.

Extended anticoagulation benefits cancer patients with distal DVT

20 Sep 2023

Alirocumab reduces LDL-C in paediatric HeFH

20 Sep 2023 by

Alirocumab administered every 2 or 4 weeks (Q2W or Q4W) significantly reduced low-density lipoprotein-cholesterol (LDL-C) levels in paediatric patients with heterozygous familial hypercholesterolaemia (HeFH), according to a study presented at ESC 2023.

Alirocumab reduces LDL-C in paediatric HeFH

20 Sep 2023

Catheter ablation boosts outcomes in patients with advanced HF

19 Sep 2023 by

Catheter ablation boosts outcomes in patients with advanced heart failure (HF) who are being considered for heart transplantation or left ventricular assist device (LVAD) implantation in the CASTLE-HTx trial presented at ESC 2023.

Catheter ablation boosts outcomes in patients with advanced HF

19 Sep 2023

Extended clopidogrel monotherapy after DAPT reduces bleeding events in ‘bi-risk’ ACS patients

16 Sep 2023 by

Extended clopidogrel monotherapy after a 9- to 12-month course of dual antiplatelet therapy (DAPT) reduces bleeding and ischaemic events in patients with acute coronary syndrome (ACS) who are at high risk for both events, according to the OPT-BIRISK* trial presented at ESC 2023.

Extended clopidogrel monotherapy after DAPT reduces bleeding events in ‘bi-risk’ ACS patients

16 Sep 2023

Traditional Chinese medicine shows benefit in HFrEF patients

12 Sep 2023 by

Treatment with qiliqiangxin (QLQX), a traditional Chinese medicine (TCM), significantly reduces the risk of hospitalization due to heart failure (HF) and cardiovascular (CV) death in patients with HF and reduced ejection fraction (HFrEF), according to the QUEST* trial presented at ESC 2023.

Traditional Chinese medicine shows benefit in HFrEF patients

12 Sep 2023

HEART-FID confirms IV iron safety for HF but falls short in efficacy

11 Sep 2023 by

The HEART-FID trial narrowly missed its primary endpoint, showing modest improvement in all-cause mortality, heart failure hospitalizations (hHF), and exercise function with ferric carboxymaltose (FCM) in HFrEF* patients with iron deficiency (ID).

HEART-FID confirms IV iron safety for HF but falls short in efficacy

11 Sep 2023

Pulsed field ablation system as good as standard-of-care ablation for paroxysmal AF

07 Sep 2023 by

In the treatment of patients with paroxysmal atrial fibrillation (AF), pulse field ablation (PFA) system appears to yield safety and efficacy outcomes that are noninferior to those of conventional thermal ablation, according to data from the ADVENT trial.

Pulsed field ablation system as good as standard-of-care ablation for paroxysmal AF

07 Sep 2023